PATENT CLAIM ANALYSIS

Application Number: 16239530
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-12
Patent Classification: ["514", "449000"]

Abstract:
Disclosed are methods useful for the therapeutic treatment of cancerous solid tumors by the administration of an antineoplastic agent, wherein the antineoplastic agent resides at the tumor site exposing the tumor to the antineoplastic agent for a sustained amount of time sufficient to stimulate the endogenous immune system of the subject resulting in the production of tumoricidal cells and infiltration of the tumoricidal cells in and around the tumor site at a level sufficient to treat the tumor. The methods include local administration methods such as topical application, pulmonary administration, intratumoral injection, and intraperitoneal injection.

Claim (Index 21):
The method  claim 1 , wherein the stimulation of the endogenous immune system produces a cellular immune response and/or a humoral immune response.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 99.0
- Lexical Diversity: 1.77193
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16007095', '12436697', '13779625', '16136502', '12334115']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7768481114919688
- 35 USC 102 Novelty (BERT): 0.5660922222652368
- Combined Prediction Score: 0.7557725225692955
- Mean Citation Score: 295.124288
- Max Citation Score: 487.44293
- Similarity Product: 324.6970498979384

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test